MapLight Therapeutics gets FDA fast track status for Alzheimer's drug Jan 5, 2026 07:03AM
Jefferies on MapLight Therapeutics (MPLT): 'Cleaner Catalyst Flow as Competitor Pushes Back Alz Psychosis Data to YE:26' Dec 3, 2025 10:44AM
Leerink Partners Starts MapLight Therapeutics (MPLT) at Outperform Nov 21, 2025 06:20AM
Jefferies Starts MapLight Therapeutics (MPLT) at Buy Nov 21, 2025 01:07AM
Stifel Starts MapLight Therapeutics (MPLT) at Buy Nov 21, 2025 01:06AM


Nov 21, 2025 12:57AM Morgan Stanley Starts MapLight Therapeutics (MPLT) at Overweight
Oct 23, 2025 11:52AM MapLight (MPLT) reportedly to stop taking IPO orders at noon Thursday
Oct 20, 2025 10:53AM MapLight Therapeutics IPO reportedly well oversubscribed
Oct 6, 2025 04:11PM MapLight Therapeutics files for 14.75M share IPO at $17/sh
Sep 19, 2025 04:15PM MapLight (MPLT) files for proposed Nasdaq IPO